iSOFT Wins new e-Prescribing Deal at Harrogate NHS Trust

iSOFTHarrogate and District NHS Foundation Trust is the latest NHS trust to place an order with iSOFT, a CSC company, for its e-prescribing and medicines administration (ePMA) solution to improve medicines management and reduce the risk of drug-related mistakes.

The move is part of the trust's commitment to ensuring safe and effective care at the 367-bed Harrogate District Hospital. The ePMA solution will integrate with the trust's existing IT infrastructure including PAS, laboratory and eDischarge systems to further promote the timely and accurate sharing of medicines related information within the trust and with GPs.

"We are dedicated to making the safety of our patients and the quality of care our highest priority," said Andrew Alldred, Harrogate's director of pharmacy. "With the proliferation of new drugs, many with similar sounding names, prescribing has become a hugely complex task that is fraught with risk. Paper-based medicines systems can no longer be relied on to meet the demanding needs of a modern and clinically complex hospital environment."

"With research suggesting that at least ten percent of medication orders contain errors, costing the NHS in excess of £500 million a year, there has never been a greater need for ePMA solutions to help improve the timeliness, appropriateness and accuracy of the prescribing and administration of medicines," said Adrian Stevens, managing director of iSOFT's UK and Ireland business. "Our solution has been shown to greatly reduce adverse medication errors and improve the efficiency of healthcare services."

Harrogate is the fourth NHS trust to become an early adopter of iSOFT's ePMA solution after Pennine Acute, Stockport and Leicester. "Harrogate is a welcome addition to the early adopter programme," Stevens said. "The trust has already achieved an impressive range of meaningful clinical engagement and we are looking forward to continuing our strategic relationship to deliver real benefits for the trust’s staff and its patients."

iSOFT ePMA provides new opportunities to improve the communication of medicines related information between medical, nursing and clinical pharmacy teams. Advanced drug formulary management underpinned by clinical and workflow based decision support provides a highly effective environment to help improve a hospital's performance in relation to medicines. In-built reporting and data analysis tools provide executive and management visibility of performance to help proactively address areas of concern or promote good practice.

iSOFT ePMA is shown to halve adverse medication errors at hospitals in Australia and New Zealand. These errors can prolong a patient's stay, which in turn blocks hospital beds and increases costs.

Related news articles:

About CSC
CSC is a global leader in providing technology-enabled business solutions and services. Headquartered in Falls Church, Va., CSC has approximately 97,000 employees and reported revenue of $16.2 billion for the 12 months ended September 30, 2011.

Most Popular Now

Stepping Hill Hospital Announced as SPAR…

Stepping Hill Hospital, part of Stockport NHS Foundation Trust, has replaced its bedside units with state-of-the art devices running a full range of information, engagement, communications and productivity apps, to...

DMEA 2025: Digital Health Worldwide in B…

8 - 10 April 2025, Berlin, Germany. From the AI Act, to the potential of the European Health Data Space, to the power of patient data in Scandinavia - DMEA 2025...

Is AI in Medicine Playing Fair?

As artificial intelligence (AI) rapidly integrates into health care, a new study by researchers at the Icahn School of Medicine at Mount Sinai reveals that all generative AI models may...

New System for the Early Detection of Au…

A team from the Human-Tech Institute-Universitat Politècnica de València has developed a new system for the early detection of Autism Spectrum Disorder (ASD) using virtual reality and artificial intelligence. The...

Generative AI's Diagnostic Capabili…

The use of generative AI for diagnostics has attracted attention in the medical field and many research papers have been published on this topic. However, because the evaluation criteria were...

Diagnoses and Treatment Recommendations …

A new study led by Prof. Dan Zeltzer, a digital health expert from the Berglas School of Economics at Tel Aviv University, compared the quality of diagnostic and treatment recommendations...

AI Tool can Track Effectiveness of Multi…

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed by UCL researchers. AI uses...

Surrey and Sussex Healthcare NHS Trust g…

Surrey and Sussex Healthcare NHS Trust has marked an important milestone in connecting busy radiologists across large parts of South East England, following the successful go live of Sectra's enterprise...

Dr Jason Broch Joins the Highland Market…

The Highland Marketing advisory board has welcomed a new member - Dr Jason Broch, a GP and director with a strong track record in the NHS and IT-enabled transformation. Dr Broch...

DMEA 2025 Ends with Record Attendance an…

8 - 10 April 2025, Berlin, Germany. DMEA 2025 came to a successful close with record attendance and an impressive program. 20,500 participants attended Europe's leading digital health event over the...

Multi-Resistance in Bacteria Predicted b…

An AI model trained on large amounts of genetic data can predict whether bacteria will become antibiotic-resistant. The new study shows that antibiotic resistance is more easily transmitted between genetically...

AI-Driven Smart Devices to Transform Hea…

AI-powered, internet-connected medical devices have the potential to revolutionise healthcare by enabling early disease detection, real-time patient monitoring, and personalised treatments, a new study suggests. They are already saving lives...